Resistance Exercise in Woman With Primary Sjörgen Syndrome.

Status Completed

Clinical Trial Summary

To analyze the effectiveness of 16-week resistance exercise in daily motor behavior and functional fitness in women with Primary Sjögren's Syndrome. The present study presents as hypothesis that a supervised resistance exercise program is effective and safe in improving the functional fitness and quality of life of patients with Primary Sjögren's Syndrome, making them more physically active, contributing positively to the capacity to perform daily life activities as household and / or professional tasks.

Clinical Trial Description

Sjögren's syndrome (SS) is a systemic autoimmune inflammatory disease that affects the exocrine glands and less frequently the internal organs, presenting intense lymphoplasmacytic infiltration mainly in the epithelium of the involved tissues, leading to the destruction and loss of the secretory function. SS can manifest itself in isolation, without association with other diseases, in this situation it is called Primary Sjögren's Syndrome (PSS), being considered the second most common autoimmune rheumatic disease, prevalent in women (9: 1). The inflammatory process can affect any organ, resulting in a generally severe clinical condition, and may involve the musculoskeletal, pulmonary, gastrointestinal, hepatic, hematological, vascular, dermatological, renal and neurological systems, leading to an evident decline of the physical functions with decrease in aerobic capacity, muscular strength, joint mobility and static balance, as well as psychological and social deficit. Patients with PSS also present a marked physiological characteristic with a high level of fatigue. Thus, resistance exercise becomes a non-drug strategy, aiming to improve musculoskeletal fitness, allowing the execution of daily activities with more independence, autonomy and safety, while influencing the patient's functional fitness. The aim of the present study is to analyze the effectiveness of resistance exercise in daily motor behavior and functional fitness in women with Primary Sjögren's Syndrome. After the use of actigraphy for 15 days, equipment that measures the level of daily physical activity, and evaluation of functional fitness, volunteers underwent a supervised resistance exercise program for 16 weeks. The following muscular clusters were exerted: latissimus dorsi, deltoid, pectoralis major , triceps brachialis, biceps brachialis, quadriceps, hamstring, thigh adductor muscles, thigh abductor muscles and gastrocnemius. The subjects performed in each exercise 3 sets of 10 maximum repetitions. The training sessions were held twice a week. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03130062
Study type	Interventional
Source	Federal University of São Paulo
Contact
Status	Completed
Phase	N/A
Start date	January 2014
Completion date	September 2015

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06440525` - A Phase 2 Study of RSLV-132 in Females With Primary Sjögren's Syndrome	Phase 2
Not yet recruiting	`NCT03140111` - LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients	N/A
Not yet recruiting	`NCT06049368` - 68Ga-P16-093 PET/CT Imaging in the Salivary Gland	Phase 1/Phase 2
Not yet recruiting	`NCT03614299` - Eye Dryness Evaluation in Primary Sjögren's Syndrome
Not yet recruiting	`NCT03126383` - Inflammatory Myopathies in Primary Sjögren's Syndrome	N/A
Recruiting	`NCT04830644` - A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.	Phase 2
Not yet recruiting	`NCT03765593` - Biomarkers in Primary Sjögren's Syndrome
Completed	`NCT01081184` - Neurotrophins Implications in Primary Sjögren Syndrome	N/A
Completed	`NCT05670535` - Sjögren and Gynecologic Considerations
Completed	`NCT03226444` - Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome	Phase 1/Phase 2
Completed	`NCT04816370` - Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions	N/A
Completed	`NCT05380804` - Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
Terminated	`NCT04700280` - A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS)	Phase 2
Completed	`NCT04093531` - Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome	Phase 1
Recruiting	`NCT03509064` - Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
Completed	`NCT04224454` - Vaccine Coverage and Primary Sjögren'Syndrome
Completed	`NCT04960605` - Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome	N/A
Recruiting	`NCT06361745` - Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.